Director and Affiliates Invest $1M in Highly Dilutive Private Placement

summarizeSummary

A director and related entities invested $1 million in IN8BIO's recent private placement, acquiring a significant stake as the company raised substantial capital.

check_boxKey Events

• Director and Affiliates Invest

  Emily Fairbairn, a director, along with Malcom Fairbairn and their charitable trust, invested $1 million in IN8BIO's private placement.

• Significant Capital Raise

  The investment was part of a larger private placement that raised approximately $20.1 million for the company.

• Substantial Beneficial Ownership

  The reporting persons now beneficially own approximately 7.5% of the company's common stock.

• Dilutive Financing

  The private placement, priced at $1.38 per share, is highly dilutive but provides critical funding for the company's operations.

auto_awesomeAnalysis

Emily Fairbairn, a director of IN8BIO, along with Malcom Fairbairn and their charitable trust, collectively invested $1 million in the company's private placement. This investment, made at $1.38 per share, is part of a larger financing round that raised approximately $20.1 million. While the private placement is highly dilutive for existing shareholders, the successful capital raise provides crucial funding for IN8BIO's operations. The participation of a director and significant investors in this round signals confidence in the company's future despite the dilutive nature of the offering.